| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BeiGene, Ltd. | Director | Ordinary Shares | 46K | $9.55M | $207.72 | Jun 5, 2024 | Direct |
| Schrodinger, Inc. | Chief Medical Officer | Common Stock | 15K | $601K | $40.06 | Aug 9, 2023 | Direct |
| Schrodinger, Inc. | Chief Medical Officer | Stock Option (right to buy) | 60K | Mar 4, 2024 | Direct | ||
| BeiGene, Ltd. | Director | Share Option (Right to Buy) | 34.2K | Jun 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BGNE | BeiGene, Ltd. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
| SDGR | Schrodinger, Inc. | Mar 4, 2024 | 1 | $0 | 4 | Mar 5, 2024 | Chief Medical Officer |
| SDGR | Schrodinger, Inc. | Aug 9, 2023 | 2 | $0 | 4 | Aug 10, 2023 | Chief Medical Officer |
| SDGR | Schrodinger, Inc. | Jul 31, 2023 | 0 | $0 | 3 | Aug 3, 2023 | Chief Medical Officer |
| BGNE | BeiGene, Ltd. | Jun 15, 2023 | 2 | $0 | 4 | Jun 20, 2023 | Director |
| BGNE | BeiGene, Ltd. | Jun 22, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
| BGNE | BeiGene, Ltd. | Feb 28, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Director |
| BGNE | BeiGene, Ltd. | Feb 1, 2022 | 0 | $0 | 3 | Feb 8, 2022 | Director |